Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma

EFE, nihal; altas, enver; MAZLUMOGLU, muhammed recai; Aktan, Bülent; ucuncu, harun; Eren, Suat; oner, fatıh

doi:10.1097/scs.0000000000002983

Makale Tam Makale Uluslararası 2016

Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma

nihal EFE, enver altas, muhammed recai MAZLUMOGLU, Bülent Aktan, harun ucuncu, Suat Eren, fatıh oner

JOURNAL OF CRANIOFACIAL SURGERY Cilt 27 · Sayı 7 · ss. 1802–1803 · 01.10.2016

DOI ile aç

Özet

Though the lymphangioma is a benign neoplasm, it may make an invasion to vital structures by progressively growing. For lymphangioma, which progressed in such a way, surgical treatment has high morbidity and recurrence risk. On these cases, OK-432 is a frequently used sclerotherapy agent. The authors report the result they obtained by the use of single-dose OK-432 on an inoperable pediatric cervical macrocystic lymphangioma case and also their experiences.

Atıf için künye

EFE, N., altas, E., MAZLUMOGLU, M. R., Aktan, B., ucuncu, H., Eren, S., & oner, F. (2016). Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma. JOURNAL OF CRANIOFACIAL SURGERY, 27(7), 1802–1803. https://doi.org/10.1097/scs.0000000000002983

BibTeX

@article{efe2016-217462,
  author = {EFE, nihal and altas, enver and MAZLUMOGLU, muhammed recai and Aktan, Bülent and ucuncu, harun and Eren, Suat and oner, fatıh},
  title = {Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma},
  journal = {JOURNAL OF CRANIOFACIAL SURGERY},
  year = {2016},
  volume = {27},
  number = {7},
  pages = {1802--1803},
  issn = {1049-2275},
  doi = {10.1097/scs.0000000000002983},
  url = {https://akademik.atauni.edu.tr/yayinlar/217462-excellent-result-with-the-use-of-single-dose-ok-432-in-cervical-macrocystic}
}